Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

1.

Reducing costs and operational constraints of dengue vector control by targeting productive breeding places: a multi-country non-inferiority cluster randomized trial.

Tun-Lin W, Lenhart A, Nam VS, Rebollar-Téllez E, Morrison AC, Barbazan P, Cote M, Midega J, Sanchez F, Manrique-Saide P, Kroeger A, Nathan MB, Meheus F, Petzold M.

Trop Med Int Health. 2009 Sep;14(9):1143-53. doi: 10.1111/j.1365-3156.2009.02341.x. Epub 2009 Jul 14.

PMID:
19624476
[PubMed - indexed for MEDLINE]
Free Article
2.

Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study.

Huy R, Wichmann O, Beatty M, Ngan C, Duong S, Margolis HS, Vong S.

BMC Public Health. 2009 May 27;9:155. doi: 10.1186/1471-2458-9-155.

PMID:
19473500
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cost of dengue cases in eight countries in the Americas and Asia: a prospective study.

Suaya JA, Shepard DS, Siqueira JB, Martelli CT, Lum LC, Tan LH, Kongsin S, Jiamton S, Garrido F, Montoya R, Armien B, Huy R, Castillo L, Caram M, Sah BK, Sughayyar R, Tyo KR, Halstead SB.

Am J Trop Med Hyg. 2009 May;80(5):846-55.

PMID:
19407136
[PubMed - indexed for MEDLINE]
Free Article
4.

Disability adjusted life years lost to dengue in Brazil.

Luz PM, Grinsztejn B, Galvani AP.

Trop Med Int Health. 2009 Feb;14(2):237-46. doi: 10.1111/j.1365-3156.2008.02203.x. Epub 2009 Jan 20.

PMID:
19171013
[PubMed - indexed for MEDLINE]
Free Article
5.

[Cost-benefit analysis of vector control in areas of potential dengue transmission].

Orellano PW, Pedroni E.

Rev Panam Salud Publica. 2008 Aug;24(2):113-9. Spanish.

PMID:
19062602
[PubMed - indexed for MEDLINE]
6.

Funding of drugs: do vaccines warrant a different approach?

Beutels P, Scuffham PA, MacIntyre CR.

Lancet Infect Dis. 2008 Nov;8(11):727-33. doi: 10.1016/S1473-3099(08)70258-5.

PMID:
18992409
[PubMed - indexed for MEDLINE]
7.

Historical analysis of the economic cost of dengue in Australia.

Canyon DV.

J Vector Borne Dis. 2008 Sep;45(3):245-8. No abstract available.

PMID:
18807382
[PubMed - indexed for MEDLINE]
Free Article
8.

Clinical characteristics and national economic cost of the 2005 dengue epidemic in Panama.

Armien B, Suaya JA, Quiroz E, Sah BK, Bayard V, Marchena L, Campos C, Shepard DS.

Am J Trop Med Hyg. 2008 Sep;79(3):364-71.

PMID:
18784227
[PubMed - indexed for MEDLINE]
Free Article
9.

Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects.

Guy B, Nougarede N, Begue S, Sanchez V, Souag N, Carre M, Chambonneau L, Morrisson DN, Shaw D, Qiao M, Dumas R, Lang J, Forrat R.

Vaccine. 2008 Oct 23;26(45):5712-21. doi: 10.1016/j.vaccine.2008.08.019. Epub 2008 Aug 30.

PMID:
18762226
[PubMed - indexed for MEDLINE]
10.

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults.

Sun W, Cunningham D, Wasserman SS, Perry J, Putnak JR, Eckels KH, Vaughn DW, Thomas SJ, Kanesa-Thasan N, Innis BL, Edelman R.

Hum Vaccin. 2009 Jan-Feb;5(1):33-40. Epub 2009 Jan 27.

PMID:
18670195
[PubMed - indexed for MEDLINE]
Free Article
11.

Quality of life of dengue patients.

Lum LC, Suaya JA, Tan LH, Sah BK, Shepard DS.

Am J Trop Med Hyg. 2008 Jun;78(6):862-7.

PMID:
18541760
[PubMed - indexed for MEDLINE]
Free Article
12.

Economic burden of dengue infections in India.

Garg P, Nagpal J, Khairnar P, Seneviratne SL.

Trans R Soc Trop Med Hyg. 2008 Jun;102(6):570-7. doi: 10.1016/j.trstmh.2008.02.015. Epub 2008 Apr 9. Review.

PMID:
18402995
[PubMed - indexed for MEDLINE]
13.

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Kim SY, Goldie SJ.

Pharmacoeconomics. 2008;26(3):191-215. Review.

PMID:
18282015
[PubMed - indexed for MEDLINE]
14.

Coping with health-care costs: implications for the measurement of catastrophic expenditures and poverty.

Flores G, Krishnakumar J, O'Donnell O, van Doorslaer E.

Health Econ. 2008 Dec;17(12):1393-412. doi: 10.1002/hec.1338.

PMID:
18246595
[PubMed - indexed for MEDLINE]
15.

The demand for a dengue vaccine: a contingent valuation survey in Metro Manila.

Palanca-Tan R.

Vaccine. 2008 Feb 13;26(7):914-23. doi: 10.1016/j.vaccine.2007.12.011. Epub 2007 Dec 31.

PMID:
18206277
[PubMed - indexed for MEDLINE]
16.

Measuring the burden of neglected tropical diseases: the global burden of disease framework.

Mathers CD, Ezzati M, Lopez AD.

PLoS Negl Trop Dis. 2007 Nov 7;1(2):e114. Review.

PMID:
18060077
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Health seeking and access to care for children with suspected dengue in Cambodia: an ethnographic study.

Khun S, Manderson L.

BMC Public Health. 2007 Sep 24;7:262.

PMID:
17892564
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti.

Suaya JA, Shepard DS, Chang MS, Caram M, Hoyer S, Socheat D, Chantha N, Nathan MB.

Trop Med Int Health. 2007 Sep;12(9):1026-36.

PMID:
17875014
[PubMed - indexed for MEDLINE]
Free Article
19.

Age and clinical dengue illness.

Egger JR, Coleman PG.

Emerg Infect Dis. 2007 Jun;13(6):924-5.

PMID:
17553238
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The economic impact of dengue hemorrhagic fever on family level in Southern Vietnam.

Harving ML, Rönsholt FF.

Dan Med Bull. 2007 May;54(2):170-2.

PMID:
17521539
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk